SPECIFIC ANTIBODIES FOR THE TREATMENT OF CHRONIC LYMPATYC LEUKEMIA THE PROJECT INVOLVES THE DEVELOPMENT OF MONOCLONAL ANTIBODIES SPECIFIC TO EACH INDIVIDUAL PATIENT (DEFINED? ANTI-IDOTYPE?) INTENDED FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR STANDARDISED CHRONIC LYMPHOCYTIC LEUKAEMIA. THE PROJECT CONSISTS OFshare on FacebookTwitterLinkedinEmailreport an issue